SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-119206
Filing Date
2018-04-17
Accepted
2018-04-17 07:46:54
Documents
60
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d506519d10k.htm 10-K 760948
2 EX-23.1 d506519dex231.htm EX-23.1 3533
3 EX-31.1 d506519dex311.htm EX-31.1 8753
4 EX-31.2 d506519dex312.htm EX-31.2 8582
5 EX-32.1 d506519dex321.htm EX-32.1 4392
  Complete submission text file 0001193125-18-119206.txt   3030923

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxgn-20171231.xml EX-101.INS 447892
7 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20171231.xsd EX-101.SCH 35553
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20171231_cal.xml EX-101.CAL 44579
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20171231_def.xml EX-101.DEF 92515
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20171231_lab.xml EX-101.LAB 302455
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20171231_pre.xml EX-101.PRE 201912
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 18757887
SIC: 2836 Biological Products, (No Diagnostic Substances)